PPARG and metabolic dysfunction-associated steatotic liver disease: With all these data surrounding the effect of Pparγ on the development of NAFLD and improvements in insulin sensitivity in several models, it is still not conclusive as to whether the nuclear receptor is beneficial or detrimental.